Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

13.04
+0.04000.31%
Post-market: 13.040.00000.00%16:24 EST
Volume:646.29K
Turnover:8.46M
Market Cap:1.02B
PE:-2.01
High:13.41
Open:13.02
Low:12.92
Close:13.00
52wk High:27.13
52wk Low:10.87
Shares:77.89M
Float Shares:59.27M
Volume Ratio:0.71
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4719
EPS(LYR):-0.0902
ROE:-38.71%
ROA:2.61%
PB:0.98
PE(LYR):-144.62

Loading ...

Integra LifeSciences Unveils New Change-in-Control Severance Program for Executives

Reuters
·
Dec 13

Integra LifeSciences Medical Director Highlights Commitment to Transformational Patient Care

Reuters
·
Dec 05

Integra welcomes policy advancements supporting Medicare beneficiary access

TIPRANKS
·
Nov 25

Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

Reuters
·
Nov 20

Integra Lifesciences (IART) Receives a Hold from Wells Fargo

TIPRANKS
·
Nov 12

BRIEF-Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

Reuters
·
Nov 12

Integra Lifesciences Receives FDA 510(K) Clearance for Use of the Cusa® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

THOMSON REUTERS
·
Nov 12

Director Makes Bold Move with Major Stock Purchase in Integra Lifesciences

TIPRANKS
·
Nov 07

Director Jeffrey A. Graves Acquires Common Shares of Integra LifeSciences Holdings Corporation

Reuters
·
Nov 07

Integra LifeSciences Price Target Cut to $13.00/Share From $15.00 by Truist Securities

Dow Jones
·
Nov 03

Stock Track | Integra Lifesciences Plummets 5% as Truist Securities Slashes Price Target

Stock Track
·
Nov 03

Stock Track | Integra Lifesciences Plummets 5.08% as Truist Securities Slashes Price Target

Stock Track
·
Nov 03

Integra LifeSciences price target lowered to $13 from $15 at Truist

TIPRANKS
·
Nov 03

Integra LifeSciences Is Maintained at Sell by Citigroup

Dow Jones
·
Nov 01

Integra Lifesciences (IART) Receives a Sell from Morgan Stanley

TIPRANKS
·
Oct 31

Integra LifeSciences price target raised to $13 from $12 at JPMorgan

TIPRANKS
·
Oct 31

Integra Lifesciences Faces Revenue Shortfall and Lowered Outlook Amid Supply Chain Challenges

TIPRANKS
·
Oct 31

Integra LifeSciences (IART): Deep Valuation Discount Tests Profitability Timeline, Spotlights Risk-Reward Divide

Simply Wall St.
·
Oct 31

Integra LifeSciences Declines on FY Outlook Cut After Supply Chain Issues

Dow Jones
·
Oct 31

Stock Track | Integra Lifesciences Plummets 6.03% as Q3 Revenue Misses Estimates and Guidance Disappoints

Stock Track
·
Oct 30